Physician profile
Grace K Wong
NPI 1073521837
$1,902.48
in general payments reported to CMS, 2019-2025
19 companies · $541 in 2025
The $541 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $18.44 · 2021: $75.46 · 2022: $255 · 2023: $216 · 2024: $568 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,226 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,226.07 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $589.44 | 2023-2025 | Veozah |
| Abbvie INC. | $272.04 | 2019-2025 | Qulipta |
| Bayer Healthcare Pharmaceuticals INC. | $190.68 | 2019-2025 | |
| Amgen INC. | $166.65 | 2019-2025 | Evenity, Prolia, Prolia |
| Exeltis, USA INC. | $126.77 | 2024-2025 | Slynd |
| Pfizer INC. | $96.26 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $78.60 | 2023-2025 | Myfembree, Gemtesa |
| Evofem Biosciences, INC. | $69.34 | 2022-2024 | |
| Coopersurgical, INC. | $49.57 | 2019-2022 | |
| Covidien LP | $38.86 | 2019 | |
| Astellas Pharma Global Development | $35.00 | 2024 | Veozah |
| Roche Diagnostics Corporation | $34.89 | 2019-2020 | |
| Myovant Sciences INC. | $27.32 | 2022 | |
| Radius Health, INC. | $26.85 | 2019 | |
| Ethicon US, LLC | $24.31 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $24.28 | 2022 | |
| Merck Sharp & Dohme LLC | $20.77 | 2023 | Vaxneuvance, Pneumovax 23, Gardasil 9 |
| Aspira Women'S Health INC | $19.47 | 2023 | Ova1 |
| Hologic Sales and Service, LLC | $11.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.